Clinical Trial Update: Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ragweed MATAMPL versus placebo for ragweed-induced seasonal allergic rhinitis has completed follow-up assessment of efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Ragweed MATAMPL

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED